<DOC>
	<DOCNO>NCT01391299</DOCNO>
	<brief_summary>This study evaluate safety efficacy botulinum toxin Type A compare placebo treatment forehead line ( facial rhytides ) also administer frown line ( glabellar rhytides ) .</brief_summary>
	<brief_title>Safety Efficacy Study Botulinum Toxin Type A Treatment Forehead Frown Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate severe forehead line Current previous botulinum toxin treatment serotype within one year Diagnosis myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis Prior facial cosmetic surgery ( e.g . prior periorbital surgery , facial lift , brow lift , eyelid lift eyebrow surgery ) Facial laser light treatment , microdermabrasion , superficial peel within 3 month Oral retinoid therapy within one year</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>